论文部分内容阅读
诺氟沙星(又名氟哌酸)是喹诺酮类广谱抗菌药,首先由日本吉林公司研究成功。由于本品抗菌谱广、副作用小且同其它抗菌药无交叉耐药性等优点而受到临床好评。但本品经口服生物利用度低,在使用范围方面受到一定限制。目前国内已研制成功诺氟沙星注射液,已由卫生部正式批准生产供应临床,有关注射液在临床治疗效果方面尚未见报道。本文根据自己研制的诺氟沙星注射液在本院进行临床疗效观察,现将观察结果报道如下:
Norfloxacin (also known as norfloxacin) is a broad-spectrum quinolone antibacterial drugs, first by the Japanese company’s success. Due to its broad antimicrobial spectrum, small side effects and no cross-resistance with other antibacterials, it has been well received by clinicians. However, this product by oral bioavailability is low, the use of the area subject to certain restrictions. At present, China has successfully developed norfloxacin injection, the Ministry of Health has officially approved the production and supply of clinical, the injection of the clinical treatment effect has not been reported. This article according to their own research norfloxacin injection in our hospital for clinical observation, the observations are reported as follows: